BAUSCH HEALTH ANNOUNCES VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION), 0.024%, IS NOW APPROVED IN SEVEN COUNTRIES

September 24, 2020

← Back to blog page

Cookies

By continuing to use this website, you agree to our Cookie Policy.